FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

40745211000001101: Jorveza 0.5mg orodispersible tablets (Dr. Falk Pharma UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 06-Jul 2022. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2310221000001116 Jorveza 0.5mg orodispersible tablets (Dr. Falk Pharma UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2310241000001114 Jorveza 0.5mg orodispersible tablets (Dr. Falk Pharma UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Jorveza 0.5mg orodispersible tablets (Dr. Falk Pharma UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Jorveza 0.5mg orodispersible tablets (Dr. Falk Pharma UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Jorveza 0.5mg orodispersible tablets (Dr. Falk Pharma UK Ltd) Is a Budesonide 500microgram orodispersible tablets sugar free true Inferred relationship Existential restriction modifier
Jorveza 0.5mg orodispersible tablets (Dr. Falk Pharma UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Jorveza 0.5mg orodispersible tablets (Dr. Falk Pharma UK Ltd) Is a Jorveza true Inferred relationship Existential restriction modifier
Jorveza 0.5mg orodispersible tablets (Dr. Falk Pharma UK Ltd) Has dispensed dose form Conventional release orodispersible tablet true Inferred relationship Existential restriction modifier
Jorveza 0.5mg orodispersible tablets (Dr. Falk Pharma UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Jorveza 0.5mg orodispersible tablets (Dr. Falk Pharma UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Jorveza 0.5mg orodispersible tablets (Dr. Falk Pharma UK Ltd) Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Jorveza 0.5mg orodispersible tablets (Dr. Falk Pharma UK Ltd) Has specific active ingredient Budesonide true Inferred relationship Existential restriction modifier
Jorveza 0.5mg orodispersible tablets (Dr. Falk Pharma UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Jorveza 0.5mg orodispersible tablets (Dr. Falk Pharma UK Ltd) 60 tablet 6 x 10 tablets Has AMP True Jorveza 0.5mg orodispersible tablets (Dr. Falk Pharma UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start